Effectiveness of COVID-19 Vaccines in Lung Cancer Patients: Navigating Challenges During the Omicron Variant Surge - Top-Institutions - MDSpire

Effectiveness of COVID-19 Vaccines in Lung Cancer Patients: Navigating Challenges During the Omicron Variant Surge

  • By

  • Seyed M. Hosseini-Moghaddam

  • Sarah Swayze

  • Jeffrey C. Kwong

  • Frances A. Shepherd

  • February 6, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Thoracic Oncology
    • Infectious Diseases
    • Epidemiology
  • #2

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Thoracic Oncology
    • Immunology
    • Infectious Diseases
  • #3

    University of Texas MD Anderson Cancer Center
    University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Thoracic Oncology
    • Clinical Epidemiology
    • Infectious Diseases
  • #4

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Thoracic Oncology
    • Infectious Diseases
    • Public Health
  • #5

    Vall d'Hebron Institute of Oncology (VHIO)
    Vall d'Hebron Institute of Oncology (VHIO)

    Barcelona, Catalonia

    Key Differentiators

    • Thoracic Oncology
    • Clinical Research
    • Infectious Diseases

Original Source(s)

Related Content